The #ECTRIMS2025 Plenary Session has kicked off! 🎥 Our Opening Video, inspired by this year’s theme, “A New Era of Precision”, captures the essence of what’s driving us forward: earlier, more accurate diagnosis of every stage of MS, & the move toward personalised care.

#ECTRIMSPodcast Episode 4️⃣ of the Year: 2024 Revisions of the McDonald Diagnostic Criteria: What Neurologists Need to Know. 🍏 Apple: https://t.co/jNBlk4loLN 🎧 Spotify: https://t.co/aZ899UgraP In this episode, @XMontalban of @cemcat_em and Jiwon Oh of @UofT discuss how the

Why guess when you can know?

🎙️ “Cognition is a window into otherwise uncaptured disease progression, and that is a reason to measure it. That then allows us to then decide if what we are doing for our patients is right.” Tom Fuchs from @AmsNeuroscience in the latest ECTRIMS Podcast on cognition 🎧 Listen

Cognitive symptoms in MS are common—but not always captured well by current tools. In our latest podcast, Vicky Leavitt from @Columbia and Tom Fuchs from @AmsNeuroscience talk about the state of cognition research, if measurement still lags behind clinical need, and how new tools

Our December 2025 Newsletter is out now! Read it here 👉 https://t.co/0cbzw7mxxS Discover this year’s key milestones — the ECTRIMS Congress, the growing impact of Patient Community Day, the 2024 McDonald criteria revisions, and our recent educational activities.

America needs you! Join U.S. Immigration and Customs Enforcement today.

🏥 Join our Clinical Case NeuroWebinar today! Explore the multifactorial decision-making behind optimal NMOSD treatments and gain expert insights on key therapeutic choices. 🗓️ 9 Dec | 🕕 18:00–19:00 CET 🔗 Register FREE via myECTRIMS: https://t.co/815XqDMtsw

🎙️ Proud milestone: More than 16,000 listeners tuned into the ECTRIMS Podcast this year...a testament to your commitment to staying informed in MS research. To close out the year, we’re featuring a weekly countdown of our top five episodes. 5️⃣ Episode of the Year — #ECTRIMS2025

How should we treat patients who remain clinically and radiologically stable but have persistently elevated NfL? Watch our #Webinar Reply: https://t.co/M4A94PBAkD #Neurology #MS #Biomarkers

Our global community came together at Patient Community Day in record numbers — today, we are proud to share its impact. The PCD 2025 Impact Report highlights an exceptional year of global connection, scientific exchange, and shared learning. This year, 2,383 people living

🚨FLIGHTSCOPE BLACK FRIDAY SALE $1,200 OFF Mevo Plus Golf Simulators!

🎥 Rewatch one of the most inspiring moments from #ECTRIMS2025! ✨ The 2025 MS Charcot Award honors Prof. Ludwig Kappos - @UniBasel_en - for decades of groundbreaking work redefining MS diagnosis, treatment & care. ▶️ Watch now: https://t.co/SVyH54lTd8 #MSResearch #Neurology

🏥 Join our Clinical Case NeuroWebinar! Explore the multifactorial decision-making behind optimal NMOSD treatments and gain expert insights on key therapeutic choices. 🗓️ 9 Dec | 🕕 18:00–19:00 CET 🔗 Register FREE via myECTRIMS: https://t.co/815XqDMtsw

⏰ Two Days Left! Apply for the 2026 ECTRIMS Fellowship Programmes and advance your career in MS, MOGAD & NMOSD research with top experts. 📅 Deadline: 1 Dec 2025, 23:59 CET 🎯 Apply now: https://t.co/mPlGZVWwKs #ECTRIMSFellowships #ECTRIMSNextGe

New MS #Spotlight: @StankoffBr (@Sorbonne_Univ @ParisBrainInst @APHP) discusses the key changes in the 2024 McDonald Criteria, making MS diagnosis more adaptable across clinical situations. 🔗 https://t.co/ZNnKhkVyIh

It’s giving minimum effort, maximum vacation vibes.

New MS #Spotlight: @StankoffBr (@Sorbonne_Univ @ParisBrainInst @APHP) highlights the breakthroughs behind the 2024 McDonald Criteria—moving toward a more universal and timely MS diagnosis framework. 🔗 https://t.co/ZNnKhkVyIh

Best of #ECTRIMS2025: Therapy Highlight In a study led by Prof Michel (@NantesUniv) using the French MS registry (>10k pts), high-efficacy therapies better controlled relapse-linked disability but did not significantly delay PIRMA vs moderate-efficacy therapies. 👉

🎥 Revisit one of the most clinically insightful #ECTRIMS2025 sessions! ✨ Session 5: Personalised Treatment Regimes in MS & Related Disorders — tailored strategies for MS, NMOSD, MOGAD & paediatric patients. ▶️ Watch now: https://t.co/NPXVUALdAm #MSResearch #Neurology

New #Webinar Highlights: See how DMTs and rehabilitation work together to slow #MS progression, boost neurological reserve & improve life quality. Read: https://t.co/QzQXOe2cC4 Watch: https://t.co/rKvCDUfD63

Lenders can more easily work with state and local agencies to find grants and programs that may help borrowers afford a home thanks to our streamlined resources. Learn how.

📢 New in @MSJ_Research: A study led by Jennifer Graves (@UCSanDiego) found no correlation between epigenetic clocks and telomere length, suggesting they capture distinct aspects of biological aging in MS. 🔗 https://t.co/fAcGJs7u95 #MS #Aging #Biomarkers

“Nurses touch every part of the MS journey — from diagnosis to aging and rehabilitation.” — Amy Perrin Ross, @LoyolaChicago 🎧 New #ECTRIMS Podcast: MS Nursing: Listening, Leadership & the Role of AI in Patient Care ➡️ Apple Podcasts: https://t.co/9QpUoWnP5M #MSNursing

🚨 Time is running out! Only 2 weeks left to apply for the 2025 ECTRIMS Fellowship Programmes — a unique opportunity to advance your career in #MultipleSclerosis research & care with support from leading experts. 📅 Deadline: 1 Dec 2025 👉 https://t.co/mPlGZVWwKs #MSResearch

“We need to understand how to use AI properly — to support patients, reduce bias, and make the most of our time together”— Miguel Ángel Cortés @cemcat_em 🎧 Hear more in MS Nursing: Listening, Leadership & the Role of AI in Patient Care ➡️ Spotify: https://t.co/uxezetBeAJ

Santa’s gone digital. Get your personalized Cameo from Santa, and give the special ones in your life a surprise they’ll never forget.